6640--BRAND NAME OR EQUAL Flow Cytometry Reagents - MPLS

Solicitation 36C26326R0072 is a five-year Indefinite-Delivery/Indefinite-Quantity (IDIQ) contract issued by the Department of Veterans Affairs, Network Contracting Office 23, for the procurement of brand-name or equal flow cytometry reagents. The contract is designed to support clinical immunophenotyping at the Minneapolis VA Health Care System, with a total period of performance running from October 1, 2026, through September 30, 2031. This duration consists of a base period followed by four one-year ordering periods. The procurement is justified as a sole-source award under FAR 6.103-1 and 12.102(a) because the required Becton Dickinson (BD) reagents are proprietary and the only products compatible with the facility's existing BD FACSCanto, FACSLyric, and FACS Lyse Wash Assistant instrumentation. The scope of work involves the supply of a specific catalog of BD reagents, including various CD antigens and fluorochromes, with estimated annual quantities ranging from 2 to 60 units per item. All deliveries and performance will occur at the Minneapolis VA Health Care System located at One Veterans Drive, Minneapolis, MN 55417. The contract is managed by Contracting Officer Traci Johannes. While the solicitation specifies that reagents must meet FDA regulatory categories such as In Vitro Diagnostic (IVD) or Analyte Specific Reagent (ASR), no specific pricing, CLIN structures, or socioeconomic set-asides are applied. Responses are required in the form of a capabilities statement submitted electronically by the August 2026 deadline.